Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance

• Asıl Yazarlar: Riccardo Vio (Yazar), Riccardo Proietti (Yazar), Matteo Rigato (Yazar), Lorenzo Arcangelo Calò (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2021-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Atrial fibrillation (AF) often coexists with chronic kidney disease (CKD), which confer to the patient a higher risk of both thromboembolic and hemorrhagic events. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic strok...